## Javan Okendo brief biography
Javan Okendo completed his PhD at the University of Cape Town (UCT), where he used multi-omics data integration approaches to understand what constitutes protection and susceptibility to TB infections in humans. He also has an MSc degree in Bioinformatics from UCT, awarded with distinction in 2018. Javan has a passion for big data analysis and translation research which informs critical policies, specifically in health. Javan is currently working as a Bioinformatics consultant for the Distributed Platform for Omics (DIPLOMICs) in Cape Town. He has also worked as a Bioinformatician with Novartis Pharma in Basel, Switzerland. Before that, he worked as a research assistant at the Centre for Research in therapeutic sciences (CREATEs), Strathmore University, Kenya. Javan Okendo is a Kenyan citizen and a South African permanent resident. His personal mission is to develop individual and organizational capacities for positive societal transformation.

![Javan Okendo](Aspose.Words.2a6a9bdd-b0f5-465f-bd15-d0f8f53f3b54.001.jpeg)

## Publications
1.  Okendo J, Okanda D. Investigating expressed RNA variants that are related to disease severity in SARS-CoV-2-infected patients with mild-to-severe disease. Egyptian Journal of Medical Human Genetics. 2022 Dec;23(1):1-7.
2.  Okendo J, Musanabaganwa C, Mwangi P, Nyaga M, Onywera H. SARS-CoV-2-positive patients display considerable differences in proteome diversity in urine, nasopharyngeal, gargle solution and bronchoalveolar lavage fluid samples. medRxiv. 2022 Jan 1.
3.  Okendo J, Okanda D, Mwangi P, Nyaga M. Proteomic deconvolution reveals distinct immune cell fractions in different body sites in SARS-Cov-2 positive individuals. medRxiv. 2022 Jan 1.
